Fluoxetine Treatment in Poststroke Depression, Emotional Incontinence, and Anger Proneness

Completed

Phase N/A Results

Summary of Purpose

To determine the efficacy and safety of the selective serotonin reuptake inhibitor fluoxetine in the treatment of poststroke emotional disturbances.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 March 2006.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Korean Ministry of Health and Welfare

Trial Design

Double-blind, randomized, placebo-controlled clinical study.

Contacts

  • Jong S. Kim, MD Department of Neurology Asan Medical Center Song-Pa PO Box 145 Seoul 138-600, South Korea

    jongskim@amc.seoul.kr